The vasculopathy of Raynaud's phenomenon and scleroderma.
about
Raynaud's phenomenon: new aspects of pathogenesis and the role of nailfold videocapillaroscopyDelocalization of Endogenous A-kinase Antagonizes Rap1-Rho-α2C-Adrenoceptor Signaling in Human Microvascular Smooth Muscle CellsRap1 GTPases: an emerging role in the cardiovasculatureCyclic AMP-Rap1A signaling activates RhoA to induce α(2c)-adrenoceptor translocation to the cell surface of microvascular smooth muscle cellsIntracellular α(2C)-adrenoceptors: storage depot, stunted development or signaling domain?In silico modeling of human α2C-adrenoreceptor interaction with filamin-2Postocclusive Hyperemia Measured with Laser Doppler Flowmetry and Transcutaneous Oxygen Tension in the Diagnosis of Primary Raynaud's Phenomenon: A Prospective, Controlled Study.The effects of tadalafil on cold-induced vasoconstriction in patients with Raynaud's phenomenon.Abnormalities in the regulators of angiogenesis in patients with sclerodermaComparison of laser Doppler imaging, fingertip lacticemy test, and nailfold capillaroscopy for assessment of digital microcirculation in systemic sclerosis.The combination of laser Doppler perfusion imaging and photoplethysmography is useful in the characterization of scleroderma and primary Raynaud's phenomenon.Abnormal fibrillin-1 expression and chronic oxidative stress mediate endothelial mesenchymal transition in a murine model of systemic sclerosis.Massage therapy techniques as pain management for erythromelalgia: a case reportSystemic sclerosis: a prototypic multisystem fibrotic disorder.α2C-adrenoceptor modulators: a patent review.Scleroderma therapy: clinical overview of current trends and future perspective.The association between vibration and vascular injury in rheumatic diseases: a review of the literature.Endocan, Novel Potential Biomarker for Systemic Sclerosis: Results of a Pilot Study.Geographic variation as a risk factor for digital ulcers in systemic sclerosis patients: a multicentre registry.Targeting Hypoxia Inducible Factors-1α As a Novel Therapy in FibrosisPrimary Raynaud phenomenon and small-fiber neuropathy: is there a connection? A pilot neurophysiologic study.A double-blind, randomized, placebo-controlled crossover trial of the α2C-adrenoceptor antagonist ORM-12741 for prevention of cold-induced vasospasm in patients with systemic sclerosis.
P2860
Q28084234-5E5E7367-75EF-4A98-898D-E1E0BE5FD3ADQ28383107-2F2D2600-E357-4838-BAA5-11CB56E2FA71Q28388330-728CCE44-1593-419F-B7D1-0992DBA0848BQ28389626-C786059E-C83D-46D7-AAC7-48F1146B0A5BQ28389791-E99C6A2B-6C35-4735-BBB1-A5327068E742Q28392073-4368DBB8-5FE4-4FF6-929A-71F7A97982C0Q30833857-CF9AA176-0F95-4557-B462-892B00CFC4B3Q33273860-826E54E1-B4D9-491D-A4A6-ABCC231B3187Q33606645-5859958B-3802-472E-8E79-7B45FA0128A2Q33653005-5E98240D-20DF-4FF0-BF29-4399D3485EDBQ33825670-69A9D02A-A761-4089-9436-D0B60BDA7A43Q34718027-5434C175-82D9-4EAE-8AFC-D2A496C3B4D3Q34936531-5271F153-DA97-459C-9392-8FB7C589F926Q35649427-B6DA7E65-BE75-4F3F-B019-BF70184F534AQ37854049-21021B0E-9F25-4D40-8648-913ED40721EAQ38046467-648B2815-66D9-475C-B8C4-88A2FA6DB9E3Q38238935-FD88D3EA-5793-487F-A235-229214E1A261Q38968206-9658E86F-486F-461C-8B43-C107BCA52BC0Q39084290-4C3BE49E-C74E-4517-BBF0-460D1A668A4BQ39370856-CDF9F984-A5B2-4A8F-997E-60143056DBE5Q42644087-50D5421F-D93D-4503-987C-392AE094F0D5Q51164087-CB5F2744-AB36-484A-9648-AB339F2221D2
P2860
The vasculopathy of Raynaud's phenomenon and scleroderma.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The vasculopathy of Raynaud's phenomenon and scleroderma.
@ast
The vasculopathy of Raynaud's phenomenon and scleroderma.
@en
type
label
The vasculopathy of Raynaud's phenomenon and scleroderma.
@ast
The vasculopathy of Raynaud's phenomenon and scleroderma.
@en
prefLabel
The vasculopathy of Raynaud's phenomenon and scleroderma.
@ast
The vasculopathy of Raynaud's phenomenon and scleroderma.
@en
P2093
P1476
The vasculopathy of Raynaud's phenomenon and scleroderma.
@en
P2093
Maqsood A Chotani
Nicholas A Flavahan
Sheila Flavahan
Srabani Mitra
P304
275-91, vi
P356
10.1016/S0889-857X(03)00021-8
P577
2003-05-01T00:00:00Z